주식 시장 뉴스
최신 금융 뉴스 · 업데이트 7월 24, 2026
Acuta Capital, Erasca (ERAS)에 투자하여 354,575주 매수로 암 표적 치료제 공략
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …
카일레라 테라퓨틱스, 뜨거운 IPO 이후 매수할 만한 종목인가?
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …
LegalZoom 주식은 CEO가 125,000주를 매입한 후 매수할 만한 가치가 있는가?
Is LegalZoom Stock a Buy After the CEO Purchased 125,000 Shares?
Despite a CEO buy signal, the panel is largely bearish due to LegalZoom's eroding moat from AI disruption, anemic margins, …
그렉 아벨, 워렌 버핏이 가장 좋아하는 주식으로 추정되는 주식을 매수 중. 당신도 사야 할까?
Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?
Panelists generally agree that Berkshire Hathaway's current cash hoard and buyback activity signal a defensive posture rather than a growth …
Patient Square는 Nektar Pharmaceuticals (NKTR) 주식 210,000주를 매수하며 큰 베팅을 합니다.
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
Panelists generally agree that Patient Square's investment in NKTR signals confidence in Rezolve-AD's Phase 2b results, but they caution about …
워렌 버핏이 수년간 해온 말. 1개의 Vanguard ETF가 그 조언을 실천합니다.
Warren Buffett Has Been Saying This for Years. 1 Vanguard ETF Puts That Advice Into Practice.
The panel agrees that VOO's high tech concentration (33%) poses significant risk, with potential for amplified volatility during corrections. They …
Ipsen : Corabotase 데이터는 눈가 주름에서 빠르고 지속적인 효능을 입증합니다.
Ipsen : Corabotase Data Demonstrate Rapid, Durable Efficacy In Glabellar Lines
Ipsen's corabotase shows promising Phase II data with rapid onset and strong 24-week durability versus Dysport, but Phase III results …
Ranger Investment이 주식 345,000주를 추가 매수했는데 워터브릿지 주식을 매수해야 할까요?
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
Despite Gemini's 'regulatory moat' argument, the panel consensus is bearish due to WaterBridge's high debt, lack of consistent profitability, and …
Lime, IPO 상장 신청 -- 대신 이 주식을 사세요
Lime Filed for an IPO -- Buy This Stock Instead
The panel consensus is bearish on Lime's IPO, citing the 'going concern' warning, Lime's debt maturity, and the risk of …
NVent Electric 이사회, 5억 달러 규모의 자사주 매입 프로그램 승인
NVent Electric Board Approves $500 Mln Share Repurchase Program
The panel is neutral on NVT's $500M, 3-year buyback program. While the program is shareholder-friendly, the delayed start and lack …
예상보다 적은 사회보장 혜택: 이 규칙을 무시하면 안 됩니다
Your Social Security Benefit Could Be Smaller Than You Expect if You Ignore This Rule
The panel discusses the Social Security earnings test, highlighting its immediate liquidity crisis for lower-income retirees and the double penalty …
헤지 펀드 델타 글로벌이 아버크롬비 & Fitch 주식 지분을 청산했습니다. 투자자를 위한 의미는 무엇일까요.
Hedge Fund Delta Global Exited Its Stake in Abercrombie & Fitch Stock. Here's What That Means for Investors.
The panel consensus is bearish on ANF, citing a forward P/E of 7x, potential margin compression, and lack of clear …